fda approves semaglutide Oral Semaglutide: First GLP-1 Weight Loss Pill FDA approves oral semaglutide for

GLP-1RA Therapy as a Chronic Flux Perturbation System-Level Energy Flux Reorganization Under Weight Loss Therapy Most weight-loss interventionsincluding exercise [49], calorie restriction [50], cold exposure [51], and selected antidiabetic agents [10, 52]ultimately increase reliance on FAO, which supplies acetyl-CoA to sustain tricarboxylic acid (TCA) cycle activity and electron transport chain (ETC)coupled adenosine triphosphate (ATP) production

Evidence strength: Low direct evidence

GLP-1 Friendly Snacks: What Works and Why Lets be honest

A provider is unlikely to take a patient off semaglutide as long as they are seeing results and not experiencing any severe side effects

Getting Semaglutide is easier, with plans to make it more available

They found both medications suppress eating but do not activate brain GLP-1 cells